Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Ken, Tanae"'
Autor:
Tomoya Maeda, Akira Matsuda, Chie Asou, Daisuke Okamura, Ken Tanae, Mika Kohri, Maho Ishikawa, Naoki Takahashi, Kunihiro Tsukasaki, Nobutaka Kawai, Norio Asou, Masami Bessho
Publikováno v:
Leukemia Research Reports, Vol 15, Iss , Pp 100231- (2021)
To determine the impact of peripheral blood (PB) Wilms’ tumour 1 (WT-1) mRNA levels in patients with primary myelodysplastic syndromes (MDS), we analysed the relationships between several clinical variables at the time of diagnosis and the haematol
Externí odkaz:
https://doaj.org/article/f91fb527f32840b09f7f919945b749a1
Autor:
Tsugumi Satoh, Hidekazu Kayano, Mika Kohri, Ken Tanae, Chie Asou, Naoki Takahashi, Kunihiro Tsukasaki, Masanori Yasuda
Publikováno v:
Journal of Clinical & Experimental Hematopathology; 2023, Vol. 63 Issue 4, p257-261, 5p
Autor:
Daisuke Okamura, Akira Matsuda, Maho Ishikawa, Tomoya Maeda, Ken Tanae, Mika Kohri, Naoki Takahashi, Nobutaka Kawai, Norio Asou, Masami Bessho
Publikováno v:
Leukemia Research Reports, Vol 3, Iss 1, Pp 24-27 (2014)
Myelodysplastic syndromes with myelofibrosis (MDS-F) is a poor prognostic hematopoietic disorder. Azacitidine was shown to prolong survival of high-risk MDS patients. However, the effects of azacitidine on MDS-F have yet to be elucidated. Azacitidine
Externí odkaz:
https://doaj.org/article/9b03b2fea13d445d9eb91ab8e6492c68
Autor:
Naoki Takahashi, Kunihiro Tsukasaki, Ken Tanae, Mika Kohri, Chie Asou, Daisuke Okamura, Maho Ishikawa, Tomoya Maeda, Nobutaka Kawai, Akira Matsuda, Tsugumi Sato, Hidekazu Kayano, Eiichi Arai, Norio Asou
Publikováno v:
Journal of clinical and experimental hematopathology : JCEH. 62(1)
Bendamustine is now recognized as a key drug for indolent B-cell lymphoma (iBCL), mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL). Skin toxicity associated with bendamustine is one of the characteristic adverse effects. We retrospec
Autor:
Chie Asou, Norio Asou, Kunihiro Tsukasaki, Masami Bessho, Nobutaka Kawai, Mika Kohri, Daisuke Okamura, Naoki Takahashi, Akira Matsuda, Tomoya Maeda, Ken Tanae, Maho Ishikawa
Publikováno v:
Leukemia Research Reports, Vol 15, Iss, Pp 100231-(2021)
To determine the impact of peripheral blood (PB) Wilms’ tumour 1 (WT-1) mRNA levels in patients with primary myelodysplastic syndromes (MDS), we analysed the relationships between several clinical variables at the time of diagnosis and the haematol
Autor:
Tomoya, Maeda, Akira, Matsuda, Chie, Asou, Daisuke, Okamura, Ken, Tanae, Mika, Kohri, Maho, Ishikawa, Naoki, Takahashi, Kunihiro, Tsukasaki, Nobutaka, Kawai, Norio, Asou, Masami, Bessho
Publikováno v:
Leukemia Research Reports
To determine the impact of peripheral blood (PB) Wilms’ tumour 1 (WT-1) mRNA levels in patients with primary myelodysplastic syndromes (MDS), we analysed the relationships between several clinical variables at the time of diagnosis and the haematol
Autor:
Akira Matsuda, Mika Kohri, Ken Tanae, Shin Arai, Kunihiro Tsukasaki, Tsuyoshi Saeki, Norio Asou, Daisuke Okamura, Yu Akuzawa, Nobutaka Kawai, Eiichi Arai, Maho Ishikawa, Naoki Takahashi, Tomoya Maeda
Publikováno v:
Leukemia research. 91
The 2017 WHO classification includes a new provisional entity of indolent T-lymphoproliferative disorders of the gastrointestinal tract (ITLPD-GIT). We investigated GI involvement of peripheral T-cell lymphoma (PTCL). Eighty-two patients were diagnos
Autor:
Mika Kohri, Norio Asou, Masami Bessho, Naoki Takahashi, Nobutaka Kawai, Ken Tanae, Daisuke Okamura, Tomoya Maeda, Akira Matsuda, Maho Ishikawa
Publikováno v:
Leukemia Research Reports, Vol 3, Iss 1, Pp 24-27 (2014)
Myelodysplastic syndromes with myelofibrosis (MDS-F) is a poor prognostic hematopoietic disorder. Azacitidine was shown to prolong survival of high-risk MDS patients. However, the effects of azacitidine on MDS-F have yet to be elucidated. Azacitidine
Publikováno v:
Journal of Clinical Oncology. 28:5097-5100
Purpose Recently, there have been reports of hepatitis B virus (HBV) reactivation after rituximab combination chemotherapy in hepatitis B surface antigen (HBsAg) –negative patients with B-cell lymphoma. In this prospective study, the frequency of a
Autor:
Jun-ichi Tamaru, Nozomi Niitsu, Jun Sakai, Tadashi Yoshino, Naoki Takahashi, Ken Tanae, Koji Nagata
Publikováno v:
Journal of clinical and experimental hematopathology : JCEH. 55(1)
A 35-year-old man was referred to our hospital because of left supraclavicular and cervical lymphadenopathies. Histopathological examination of the lymph nodes revealed reactive lymphadenopathy. He visited our hospital three years after the initial d